MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • A Novel paradigm for the recording of col-cap movements and muscle activity in Cervical Dystonia

    O. Killian, S. Jimenez, A. Gill, C. Fearon, L. Williams, S. O'Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)

  • A novel pro-drug overcomes short-half life and absorption challenges and increase brain penetration of dopamine as a potential therapy for Parkinson’s disease

    C. Moussa (Washington DC, USA)

  • A Novel SPG11 Splice-Site Mutation in Hereditary Spastic Paraplegia: Clinical, Radiologic, and Genetic Insights from the First Philippine Case

    E. Naoe (Manila, Philippines)

  • A Novel Therapeutic Targeting the tPA-NMDAr Interaction for Multiple System Atrophy

    N. Delétage, F. Lesept, A. Henriques, N. Callizot, E. Bezard, M. Blanc (Lyon & Caen, France)

  • A Novel VAC14 Variant Associated With Levodopa-responsive Generalized Dystonia

    G. Urciuolo, J. Yomtoob, T. Fonseca, T. Abramova, L. Kinsley, L. Verhagen, N. Mencacci (Rome, Italy)

  • A Patient-Directed AI-Enabled Platform for Continuous Personalised Parkinson’s Management

    E. Meinert, J. Schivers, A. Ananthakrishnan, C. Carroll (Newcastle, United Kingdom)

  • A Phase 1b Study to Investigate Safety, Tolerability and Biomarker Responses of Repeated Subcutaneous Doses of HER-096 in Subjects with Parkinson’s Disease

    K. Holmström, K. Jääskeläinen, N. Kulesskaya, A. Ludwig, J. Koskinen, A. Vuolanto, A. Domanska, M. Engström, S. Määttänen, P. Vainio, M. Scheinin, C. Videbaek, Z. Lovro, F. Scheperjans, J. Rinne, H. Huttunen (Espoo, Finland)

  • A Phase 3, Multinational, Randomized, Placebo-Controlled, Double-Blind, Crossover Trial (IB1001-304) Evaluating Levacetylleucine in CACNA1A Disorders

    B. Zanrucha, T. Bremova-Ertl, M. Patterson, M. Strupp, J. Kerthi, J. Raymond, T. Fields, I. Billington, K. Martakis (Austin, USA)

  • A Phase I Multicenter Trial of a Novel Gene Therapy BBM-P002 for Parkinsons Disease

    M. Niu, J. Lin, J. Liu (Shanghai, China)

  • A Pilot Study of Phosphorylated Alpha-Synuclein Detection and Quantitation from Routine Colonic Biopsies in Patients with Parkinson’s disease

    T. Levine, R. Freeman, B. Bellaire, J. Parent, S. Marcotte, M. Duval, C. Gibbons (Boston, USA)

  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley